Clinical Trial Update: Enoxaparin in Acute Venous Thromboembolic Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating enoxaparin for acute venous thromboembolism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Lovenox (enoxaparin)

Snippet

Sponsor: Sanofi | Conditions: Venous Thrombosis | Phase 4 | Status: COMPLETED